The Role of Immunotherapy in Non Small Cell Lung Cancer NSCLC

0 Views

07/07/23

Renato Martins, MD, MPH, Medical Director, Outpatient General Oncology/Hematology, Seattle Cancer Care Alliance; Medical Director, Thoracic/Head and Neck Oncology; Professor, University of Washington School of Medicine, presents the Role of Immunotherapy in Non-Small Cell Lung Cancer (NSCLC). Discussion includes:
• Current non-small cell lung cancer (NSCLC) treatment planning with treatment algorithm
• Present and evolving uses of PD-1 inhibitors in NSCLC—clinical evidence (including PD-L1+ biomarker status/results)
• Additional immunotherapies in development for NSCLC: PD-L1 inhibitors (status and clinical results)
• Case study and expert interpretation
• Live Q & A Session